Get the Stockscreener App
0.9175
12.62%
-0.1325
Pre-market:
.95
0.0325
+3.54%
Palisade Bio Inc Stock (PALI) Forecast
The Palisade Bio Inc (PALI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $61.94, representing a +6,651% increase from the current price of $0.9175. The highest analyst price target is $61.40, and the lowest is $62.49.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PALI Price Target
Average 60.78
(+6,525% Upside)
Is Palisade Bio Inc (PALI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.50 | Neutral |
| STOCH(9,6) | 51.87 | Neutral |
| STOCHRSI(14) | 69.43 | Neutral |
| MACD(12,26) | -0.1058 | Buy |
| ADX(14) | 32.09 | Buy |
| William %R | -57.90 | Neutral |
| CCI(14) | 31.12 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8705
Buy
|
0.9096
Buy
|
| MA20 |
0.909
Buy
|
0.9643
Sell
|
| MA50 |
1.3035
Sell
|
1.2803
Sell
|
| MA100 |
1.8872
Sell
|
1.8591
Sell
|
| MA200 |
2.9383
Sell
|
3.0528
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, PALI could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on PALI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.5 indicates that PALI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 51.87 indicates that PALI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.43 indicates that PALI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.09 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 31.12 indicates that PALI is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PALI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Palisade Bio Inc financial reports and earnings history, Palisade Bio Inc (PALI) stock could reach $59.52 by 2030, $599.52 by 2040 and $875.57 by 2050. See the projected annual prices until 2050 of the Palisade Bio Inc stock below:
- Palisade Bio Inc (PALI) is expected to reach an average price of $293.97 in 2035, with a high prediction of $302.35 and a low estimate of $294.12. This indicates an $31,940% rise from the last recorded price of $0.9175.
- Palisade Bio Inc (PALI) stock is projected to chart a bullish course in 2040, with an average price target of $607.52, representing an $66,115% surge from its current level. The forecast ranges from a conservative $30.66 to a sky-high $599.52.
- Our analysts predict Palisade Bio Inc (PALI) to jump 41,055% by 2045, soaring from $377.69 to an average price of $377.60, potentially reaching $391.64. While $377.69 is the low estimate, the potential upside is significant.
- Palisade Bio Inc (PALI) stock is expected to climb by 2050, reaching an average of $864.43, a $94,116% jump from its current level. However, a wide range of estimates exists, with high and low targets of $875.57 and $870.93, respectively, highlighting the market's uncertainty.
Palisade Bio Inc Stock (PALI) Year by Year Forecast
Palisade Bio Inc Stock (PALI) Price Forecast for 2025
Palisade Bio Inc Stock (PALI) is expected to reach an average price of $56.47 in 2025, with a high prediction of $69.66 and a low estimate of $43.28. This indicates an +6,055% rise from the last recorded price of $0.9175.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $64.28 | $62.49 | $61.40 | +6,906% |
| May, 2025 | $59.44 | $63.67 | $64.30 | +6,378% |
| June, 2025 | $55.18 | $60.97 | $59.09 | +5,914% |
| July, 2025 | $70.18 | $69.15 | $69.66 | +7,549% |
| August, 2025 | $69.78 | $69.15 | $69.11 | +7,505% |
| September, 2025 | $67.15 | $67.24 | $67.86 | +7,219% |
| October, 2025 | $64.60 | $66.31 | $66.43 | +6,941% |
| November, 2025 | $63.18 | $63.21 | $63.29 | +6,786% |
| December, 2025 | $59.59 | $59.63 | $62.48 | +6,395% |
Palisade Bio Inc Stock (PALI) Price Forecast for 2026
The predicted value for Palisade Bio Inc (PALI) in 2026 is set at an average of $41.61. Estimates vary from a peak of $58.67 to a trough of $24.55, indicating an +4,435% surge from the present price of $0.9175.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $56.83 | $57.08 | $58.67 | +6,094% |
| February, 2026 | $54.15 | $54.28 | $55.90 | +5,802% |
| March, 2026 | $49.95 | $51.91 | $53.40 | +5,344% |
| April, 2026 | $48.32 | $48.38 | $50.27 | +5,167% |
| May, 2026 | $45.77 | $45.82 | $47.51 | +4,889% |
| June, 2026 | $42.52 | $42.65 | $44.92 | +4,534% |
| July, 2026 | $38.46 | $38.66 | $41.82 | +4,092% |
| August, 2026 | $37.27 | $37.26 | $37.72 | +3,962% |
| September, 2026 | $33.72 | $33.73 | $36.53 | +3,575% |
| October, 2026 | $30.95 | $30.97 | $32.99 | +3,273% |
| November, 2026 | $28.09 | $28.14 | $30.12 | +2,961% |
| December, 2026 | $24.52 | $24.55 | $27.37 | +2,572% |
Palisade Bio Inc Stock (PALI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Palisade Bio Inc (PALI) is $72.27, with a high forecast of $143.49 and a low forecast of $1.0431. This indicates an +7,776% increase from the last price of $0.9175.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.70 | $21.72 | $23.71 | +2,265% |
| February, 2027 | $18.93 | $18.94 | $20.98 | +1,963% |
| March, 2027 | $15.50 | $15.52 | $17.42 | +1,590% |
| April, 2027 | $12.71 | $12.71 | $14.76 | +1,286% |
| May, 2027 | $6.1179 | $6.4179 | $11.97 | +566.80% |
| June, 2027 | $115.84 | $1.0431 | $107.84 | +12,526% |
| July, 2027 | $103.67 | $107.17 | $104.51 | +11,199% |
| August, 2027 | $102.00 | $100.34 | $98.92 | +11,017% |
| September, 2027 | $90.41 | $97.41 | $101.67 | +9,754% |
| October, 2027 | $106.24 | $93.50 | $87.74 | +11,480% |
| November, 2027 | $121.07 | $113.83 | $112.49 | +13,096% |
| December, 2027 | $156.24 | $135.66 | $143.49 | +16,929% |
Palisade Bio Inc Stock (PALI) Price Forecast for 2028
In 2028, Palisade Bio Inc (PALI) is projected to reach an average price of $143.16, with a high projection of $154.20 and a low estimate of $132.11. This indicates an +15,503% rise from the last price of $0.9175.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $152.82 | $152.65 | $149.07 | +16,556% |
| February, 2028 | $151.40 | $153.27 | $151.57 | +16,402% |
| March, 2028 | $138.56 | $138.56 | $142.23 | +15,002% |
| April, 2028 | $145.89 | $142.64 | $141.09 | +15,801% |
| May, 2028 | $151.64 | $152.56 | $154.20 | +16,427% |
| June, 2028 | $149.72 | $149.74 | $147.57 | +16,218% |
| July, 2028 | $142.97 | $144.96 | $148.95 | +15,482% |
| August, 2028 | $150.38 | $143.50 | $146.88 | +16,290% |
| September, 2028 | $146.31 | $146.96 | $148.23 | +15,847% |
| October, 2028 | $143.08 | $143.54 | $143.75 | +15,494% |
| November, 2028 | $136.67 | $136.81 | $141.17 | +14,796% |
| December, 2028 | $131.39 | $132.11 | $135.13 | +14,221% |
Palisade Bio Inc Stock (PALI) Price Forecast for 2029
The 2029 price forecast for Palisade Bio Inc Stock (PALI) is $95.10 on average, with a high prediction of $129.17 and a low estimate of $61.04. This represents an +10,265% increase from the previous price of $0.9175.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $123.00 | $126.46 | $129.17 | +13,306% |
| February, 2029 | $120.29 | $120.42 | $122.41 | +13,010% |
| March, 2029 | $114.55 | $114.65 | $117.56 | +12,385% |
| April, 2029 | $109.17 | $109.26 | $112.86 | +11,798% |
| May, 2029 | $102.20 | $102.27 | $107.59 | +11,039% |
| June, 2029 | $96.84 | $96.97 | $100.73 | +10,455% |
| July, 2029 | $91.37 | $91.47 | $95.38 | +9,859% |
| August, 2029 | $83.93 | $84.03 | $89.70 | +9,047% |
| September, 2029 | $77.75 | $77.80 | $82.07 | +8,374% |
| October, 2029 | $72.24 | $72.32 | $76.33 | +7,773% |
| November, 2029 | $66.70 | $66.72 | $70.83 | +7,170% |
| December, 2029 | $60.96 | $61.04 | $65.25 | +6,544% |
Palisade Bio Inc Stock (PALI) Price Forecast for 2030
Palisade Bio Inc Stock (PALI) is expected to reach an average price of $119.60 in 2030, with a high forecast of $230.76 and a low forecast of $8.4462. This signifies an +12,936% surge from the last price of $0.9175.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $53.89 | $53.99 | $59.52 | +5,773% |
| February, 2030 | $48.20 | $48.23 | $52.45 | +5,153% |
| March, 2030 | $42.62 | $42.63 | $46.78 | +4,546% |
| April, 2030 | $36.88 | $36.95 | $41.18 | +3,920% |
| May, 2030 | $30.00 | $30.01 | $35.46 | +3,169% |
| June, 2030 | $24.35 | $24.37 | $28.55 | +2,554% |
| July, 2030 | $11.59 | $12.98 | $22.89 | +1,163% |
| August, 2030 | $239.63 | $8.4462 | $230.76 | +26,018% |
| September, 2030 | $208.13 | $226.63 | $226.01 | +22,584% |
| October, 2030 | $225.00 | $219.00 | $217.50 | +24,423% |
| November, 2030 | $196.49 | $206.49 | $200.75 | +21,316% |
| December, 2030 | $213.99 | $206.57 | $212.49 | +23,223% |
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):